https://www.biopharm.org.tw
+886-2-2655-8135
services@biopharm.org.twServices/Pipelines & Platforms
AI agent-powered OoC: This solution integrates organ-on-chip with Molecular Devices’ high-content imaging, precisely simulating human organ functions. AI agents assist in experiment design, standardization, and automation, enhancing model accuracy and reliability. They enable rapid generation of large datasets across conditions, supporting validated analysis and decision-making. This setup provides a robust foundation for evaluating drug efficacy and safety in development, advancing precision in chronic disease research.
Organ modeling: Our platforms provide comprehensive solutions for chip design, manufacturing, and verification, simulating personalized conditions for disease models like COPD and CF to advance research and treatment. Paired with the MPS system, they support dynamic tissue cultures for long-term studies, mimicking blood flow and stress. Enabling multi-cell co-culture with over 10 tissue types, they enhance nutrient delivery and reduce hypoxia, ensuring stable growth for chronic drug research.
Business Interests
In-Licensing, Out-Licensing, Collaborative R&D, CDMO, CRO, Strategic Alliance, Investment & Funding Partnerships
Contact Info
HUANG, CHIEN-YU.
Director of PMO
+886-3-6126258 #14
joyce.huang@anivance.io